CW
BIIB icon

Connectus Wealth’s Biogen BIIB Stock Holding History

Connectus Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$391K Hold
1,814
– – 0.01% 308
2023
Q4 		$469K Sell
1,814
-300
-14% -$73.7K 0.01% 411
2023
Q3 		$543K Buy
2,114
+250
+13% +$66.9K 0.01% 384
2023
Q2 		$531K Sell
1,864
-28
-1% -$8.34K 0.01% 345
2023
Q1 		$526K Buy
1,892
+50
+3% +$13.8K 0.01% 336
2022
Q4 		$510K Sell
1,842
-329
-15% -$92.9K 0.01% 340
2022
Q3 		$580K Hold
2,171
– – 0.01% 389
2022
Q2 		$443K Sell
2,171
-7
-0.3% -$1.43K 0.01% 349
2022
Q1 		$523K Sell
2,178
-1,842
-46% -$401K 0.02% 303
2021
Q4 		$965K Buy
+4,020
New +$1.03M 0.04% 222

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connectus Wealth's BIIB Position: Q1 2024 in Review

Connectus Wealth held its Biogen (BIIB) position steady in Q1 2024 at 1,814 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #308.

Connectus Wealth first reported a position in BIIB in Q4 2021 and has held it in 10 quarters since. The position peaked at $965K in Q4 2021. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Connectus Wealth held 1,814 shares of Biogen worth $391K as of Q1 2024.
  • Connectus Wealth left its Biogen share count unchanged in Q1 2024.
  • Biogen made up 0.01% of Connectus Wealth's portfolio in Q1 2024, its #308 holding.
  • Connectus Wealth first reported a position in Biogen in Q4 2021 and has held it in 10 quarters since.
  • Connectus Wealth's Biogen position peaked at $965K in Q4 2021.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.